1. P079 Attenuation of inflammation and histologic production-dependent improvement by engineered high acetate producing Saccharomyces boulardii in DSS-induced colitis. (30th January 2023) Authors: Deleu, S; Trindade de Carvalho, B; Jacobs, I; Arnauts, K; Deprez, L; Vissers, E; Lenfant, M; De Hertogh, G; Huys, G; Thevelein, J; Raes, J; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P082 Assessment of anti-inflammatory effect of high acetate administration in UC patient-derived epithelial monolayer cultures. (27th May 2021) Authors: Deleu, S; Arnauts, K; Machiels, K; Huys, G R B; Thevelein, J; Raes, J; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P095 Anti-inflammatory effect of high acetate concentration on organoid-derived epithelial monolayer from patients with Ulcerative Colitis. (21st January 2022) Authors: Deleu, S; Arnauts, K; Machiels, K; Huys, G R B; Thevelein, J; Raes, J; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗